History
To view Bard's 100th anniversary website go to www.bard100.com.
A LONG HISTORY OF TECHNOLOGICAL INNOVATION
Nearly 100 years ago, Charles Russell Bard began research for the treatment of urinary discomfort. This led to the development of the first balloon catheter in cooperation with Dr. Frederick E.B. Foley. Clinicians embraced the Foley Catheter, one of many innovations developed by C. R. Bard, Inc. A sampling of other company highlights follows.
Historical Highlights
| 1907 |
-- |
Company founder, Charles R. Bard, begins importing GOMENOL to relieve urinary discomfort. |
| |
| 1923 |
-- |
C. R. Bard, Inc. formally incorporated |
| |
| 1926 |
-- |
Charles R. Bard sells company to John F. Willits and Edson L.Outwin for $18,000.00 |
| |
| 1934 |
-- |
First marketing of Foley Catheter |
| |
| 1940 |
-- |
Bard begins distribution of the first American Woven Catheter |
| |
| 1948 |
-- |
Headquarters moved from New York City to Summit, New Jersey. Net sales exceed $1 million. |
| |
| 1954 |
-- |
Development of the first Arterial Prosthesis by Dr. DeBakey. |
| |
| 1957 |
-- |
Bard produces first sterile-packaged Foley Catheters. |
| |
| 1958 |
-- |
Bard develops first Bipolar Temporary Pacing Catheters. |
| |
| 1960 |
-- |
Another first for Bard -- latex balloon catheters. |
| |
| 1961 |
-- |
Products begin for Cardiology, Radiology, and Anesthesiology. |
| |
| 1963 |
-- |
Bard produces first disposable pre-packaged catheterization kit. C. R. Bard, Inc. becomes publicly-owned company. |
| |
| 1964 |
-- |
In-plant manufacture of medical plastic tubing. |
| |
| 1966 |
-- |
Bard acquires USCI, cementing a 25-year association. |
| |
| 1968 |
-- |
Bard is listed on New York Stock Exchange. Manufacturing plant opens in Murray Hill, New Jersey. |
| |
| 1974 |
-- |
Manufacturing bases established in South America and Japan. |
| |
| 1975 |
-- |
Bard acquires William Harvey Research Corp., expanding cardiopulmonary products for open heart and bypass surgery. |
| |
| 1978 |
-- |
Bard acquires rights to first PTCA catheter. |
| |
| 1979 |
-- |
Manufacture of Gruentzig Balloon-Tipped Angioplasty Catheter. |
| |
| 1980 |
-- |
Davol Inc., acquired; Bard develops first PTCA Guide Catheter. |
| |
| 1981 |
-- |
Puerto Rico and Ireland manufacturing facilities established. |
| |
| 1982 |
-- |
Bard develops first PTCA wire. |
| |
| 1984 |
-- |
Development of first PDA (Patent Ductus Arteriousis) device. |
| |
| 1986 |
-- |
Bard develops first ASD (Arthrectomy) device. Bard acquires American Endoscopy, Inc.. |
| |
| 1987 |
-- |
Bard European operation reorganized. |
| |
| 1989 |
-- |
Bard acquires Catheter Technology Corporation (Cath-Tech), yields GROSHONG® Catheter. Acquisition yields BIOPTY® Biopsy Instrument. Becomes Bard Access Systems, Inc. in 1991. |
| |
| 1990 |
-- |
Bard Electrophysiology formed. Bard Interventional Products, Bard Peripheral Technologies, and Specialty Access Products Business Group created. |
| |
| 1993 |
-- |
Bard acquisitions yield Autotransfusion, Angioplasty, Diagnostic, and Urinary Incontinence products. |
| |
| 1994 |
-- |
Net sales exceed $1 billion. Angiomed AG, Cardial S.A., and Vas-Cath, Inc. acquired. |
| |
| 1995 |
-- |
Bard Corporate Healthcare Services formed. Bard acquires MedChem Products, Inc. (topical hemostasis), American Hydrosurgical (laparoscopic irrigation products), and GESCO (PICC and midline access products). |
| |
| 1996 |
-- |
Bard acquires IMPRA, Inc. (vascular prosthetics), Cardiac Assist Division of St. Jude (intra-aortic balloon pumps and catheters) and X-Trode S.r.l. (stents). Bard Medical Products (surgical suction and irrigation, skin and wound care, Foley catheters) formed from Davol, Bard Urological and Bard Patient Care. |
| |
| 1997 |
-- |
Bard transitions to global Disease State Management focus. |
| |
| 1998 |
-- |
Bard sells Coronary Cath Lab business (Angiography & Angioplasty) to Arterial Vascular Engineering (AVE). Bard sells Diagnostic Sciences to Polymedco. Bard sells Global Intra-Aortic Balloon Products to Arrow International, Inc. Bard's Access Division purchases Dymax, Pittsburgh, PA. Ultrasound Vascular Access Guidance Business. |
| |
| 1999 |
-- |
Bard aquires Dymax and its SITE RITE® II Ultrasound Vascular Access Technology.
Bard sells its Cardiopulmonary division to LifeStream. |
| |
| 2000 |
-- |
Bard acquires the assets of Surgical Sense, Inc. and its Kugel Patch product line.
Bard acquires the assets of Mill-Rose Laboratories, Inc., a worldwide leader of bronchoscopy devices. |
| |
| 2003 |
-- |
Bard acquires the assets of Source Tech Medical, L.L.C. and its Iodine Radioactive Isotope Seed business for Brachytherapy.
Bard acquires Vacuum-Assisted Biopsy Device Technology from Biomedical Instruments and Products GmbH. |
|
|
2004
|
-- |
Bard acquires assets of ONUX Medical and its Salute® fixation system for hernia and soft tissue repair.
Bard acquires Bridger Biomed, Inc., including its ePTFE technology as an anti-adhesion barrier for hernia mesh products.
Bard acquires the RespiShield suction catheter product line from Sorenson Medical.
Bard divests certain assets of its Endoscopic Technologies division to CONMED.
|
| |
|
2005
|
-- |
Bard acquires certain assets of GENYX Medical, Inc. and the next generation bulking agent for female incontinence.
|
| |
|
2006
|
-- |
Bard acquires certain assets from PST, LLC related to new self-expanding nitinol stents technology. |
| |
|
2006
|
-- |
Bard acquires Venetec International, Inc. Venetec's StatLock® line of catheter securement products will be marketed by Bard’s Medical division, located in Covington, Georgia. |
| |
| 2008 |
-- |
Bard acquires LifeStent® from Edwards Lifesciences. Bard's Peripheral Vascular Divison, located in Tempe, Arizona, will market the product. |
|
|
|
|
|
|
|
|
| ![[spacer image]](/images/spacer.gif) |
![[spacer image]](/images/common/spacer.gif){kind=small}